We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current INTS market cap is 8.74M. The company's latest EPS is USD -1.0716 and P/E is -0.52.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.35M | -4.74M | -5.07M | -3.57M | -3.2M |
| Net Income | -3.17M | -4.6M | -4.97M | -3.51M | -3.18M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -6.22M | -8.01M | -7.63M | -8.32M | -16.59M |
| Net Income | -6.03M | -7.9M | -7.58M | -11.86M | -16.27M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 17.3M | 12.41M | 8.67M | 5.21M | 4.78M |
| Total Liabilities | 4.13M | 2.69M | 3.33M | 2.43M | 1.87M |
| Total Equity | 13.16M | 9.72M | 5.35M | 2.78M | 2.92M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 10.15M | 5.22M | 1.76M | 17.3M | 4.78M |
| Total Liabilities | 1.71M | 3.9M | 6.85M | 4.13M | 1.87M |
| Total Equity | -1.56M | -8.68M | -15.1M | 13.16M | 2.92M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -7.21M | -4.37M | -8.58M | -12.55M | -15.22M |
| Investing | -6.02M | 3.26M | 3.25M | 6.35M | 6.35M |
| Financing | 20.47M | 8k | 11k | 424k | 2.9M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -5.37M | -6.83M | -5.48M | -7.21M | -15.22M |
| Investing | 4.57M | N/A | N/A | -6.02M | 6.35M |
| Financing | 6.29M | 2.05M | 2.25M | 20.47M | 2.9M |
| Market Cap | 8.74M |
| Price to Earnings Ratio | -0.52 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 3.28 |
| Price to Book Ratio | 2.91 |
| Dividend Yield | - |
| Shares Outstanding | 15.18M |
| Average Volume (1 week) | 346.52k |
| Average Volume (1 Month) | 83.61k |
| 52 Week Change | -85.12% |
| 52 Week High | 5.275 |
| 52 Week Low | 0.56 |
| Spread (Intraday) | 0.02 (3.84%) |
| Company Name | Intesity Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https:// |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
